Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma

Authors

Benjamin A. Derman, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA. bderman@medicine.bsd.uchicago.edu.
Andrzej J. Jakubowiak, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA.
Michael A. Thompson, Advocate Aurora HealthFollow

Recommended Citation

Derman BA, Jakubowiak AJ, Thompson MA. Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma. Blood Cancer J. 2022;12(7):108. Published 2022 Jul 11. doi:10.1038/s41408-022-00705-6

Affiliations

Aurora Cancer Care

Type

Letter

PubMed ID

35821020